Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X


press

Mission Bio wins CYTO Innovation and QB3@953 Amgen Golden Ticket Awards

Mission Bio recently won two awards in June 2016, including the CYTO Innovation Award at CYTO 2016 in Seattle, Washington, and the QB3@953 Amgen Golden Ticket Award. The CYTO Innovation Award recognizes the best presentation from the CYTO 2016 Technology Showcase, which highlights novel technologies for cell analysis that are in early stages of development to commercialization. The QB3@953 Amgen Golden Ticket Award supports the research and development efforts of startups with one year of lab space at the QB3@953 incubator, along with access to the scientific and business expertise from Amgen. Read more


press
Mission Bio Launches Single-cell Multi-omics System for Faster, More Successful Development of Precision Cancer Therapies
press
New Study, Published in Nature, Reveals Clonal Complexity Driving Cancer Progression and Treatment Resistance with Mission Bio’s Single-cell Multi-omics Platform
press
First Peer-Reviewed Study Using Mission Bio’s Single-Cell DNA and Protein Capability Uniquely Reveals Clonal Diversity Underlying AML and Therapy Resistance
press
New Publication Highlights the Power of the Mission Bio Tapestri Platform to Monitor Therapy Response and Measure Potential Cancer Relapse
REQUEST QUOTE